The HemOnc Pulse cover image

Sagar Lonial, MD, FACP, on Why This MRD Approach Is ’Premature’ in MM

The HemOnc Pulse

00:00

The Importance of Monitoring MRD Negativity

I think the question about timing of MRD and sustained MRD negativity is one that the field is beginning to coalesce around. I feel uncomfortable making clear claims about using MRD to make treatment decisions. Long follow up is really important. You need to know what happens in 10 years. And looking at a six month endpoint and saying, I can predict to 10 years, what's going to happen is a little premature.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app